Participatory Disease Surveillance Systems: Ethical Framework.

ethics influenza, human public health surveillance research smartphone

Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
23 05 2019
Historique:
received: 20 09 2018
accepted: 29 03 2019
revised: 08 03 2019
entrez: 25 5 2019
pubmed: 28 5 2019
medline: 15 2 2020
Statut: epublish

Résumé

Advances in information technology are changing public health at an unprecedented rate. Participatory surveillance systems are contributing to public health by actively engaging digital (eg, Web-based) communities of volunteer citizens to report symptoms and other pertinent information on public health threats and also by empowering individuals to promptly respond to them. However, this digital model raises ethical issues on top of those inherent in traditional forms of public health surveillance. Research ethics are undergoing significant changes in the digital era where not only participants' physical and psychological well-being but also the protection of their sensitive data have to be considered. In this paper, the digital platform of Influenzanet is used as a case study to illustrate those ethical challenges posed to participatory surveillance systems using digital platforms and mobile apps. These ethical challenges include the implementation of electronic consent, the protection of participants' privacy, the promotion of justice, and the need for interdisciplinary capacity building of research ethics committees. On the basis of our analysis, we propose a framework to regulate and strengthen ethical approaches in the field of digital public health surveillance.

Identifiants

pubmed: 31124466
pii: v21i5e12273
doi: 10.2196/12273
pmc: PMC6660191
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12273

Informations de copyright

©Lester Darryl Geneviève, Andrea Martani, Tenzin Wangmo, Daniela Paolotti, Carl Koppeschaar, Charlotte Kjelsø, Caroline Guerrisi, Marco Hirsch, Olivia Woolley-Meza, Paul Lukowicz, Antoine Flahault, Bernice Simone Elger. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 23.05.2019.

Références

Am J Public Health. 2004 Jun;94(6):918-22
pubmed: 15249289
J Biomed Inform. 2002 Jun;35(3):178-85
pubmed: 12669981
Am J Public Health. 2015 Oct;105(10):2124-30
pubmed: 26270299
Bioethics. 2016 Nov;30(9):721-732
pubmed: 27628305
J Infect Dis. 2016 Dec 1;214(suppl_4):S386-S392
pubmed: 28830105
Eur J Hum Genet. 2013 Sep;21(9):897-902
pubmed: 23299918
Am J Bioeth. 2013;13(4):40-2
pubmed: 23514395
PLoS One. 2013 Sep 11;8(9):e73675
pubmed: 24040020
Epidemics. 2015 Dec;13:28-36
pubmed: 26616039
N Engl J Med. 2013 Oct 24;369(17):1651-8
pubmed: 24144394
Hum Vaccin Immunother. 2014;10(3):536-43
pubmed: 24343049
Lancet Oncol. 2006 Mar;7(3):266-9
pubmed: 16510336
PLoS One. 2017 Jan 11;12(1):e0169801
pubmed: 28076411
N Engl J Med. 2009 May 21;360(21):2153-5, 2157
pubmed: 19423867
JMIR Public Health Surveill. 2018 Oct 10;4(4):e67
pubmed: 30305258
PLoS Comput Biol. 2015 Feb 09;11(2):e1003904
pubmed: 25664461
J Am Med Inform Assoc. 2004 Mar-Apr;11(2):129-40
pubmed: 14662803
JAMA. 2009 Jul 1;302(1):67-72
pubmed: 19567441
BMJ. 2015 May 07;350:h2146
pubmed: 25952952
J Med Internet Res. 2014 Jul 16;16(7):e172
pubmed: 25048379
Am J Public Health. 2014 Apr;104(4):596-602
pubmed: 24524499
Am J Public Health. 2012 Dec;102(12):2225-30
pubmed: 23078484
BMC Public Health. 2014 Sep 20;14:984
pubmed: 25240865
Eur J Hum Genet. 2016 Jul;24(7):956-60
pubmed: 26554881
Vaccine. 2009 Oct 23;27(45):6353-7
pubmed: 19840672
EMBO Rep. 2006 Jul;7(7):661-6
pubmed: 16819458
J Infect Dis. 2016 Dec 1;214(suppl_4):S375-S379
pubmed: 28830113
Ann Epidemiol. 2017 May;27(5):297-301
pubmed: 28595734
Am J Public Health. 2008 May;98(5):793-801
pubmed: 18382010
Biopreserv Biobank. 2014 Dec;12(6):423-9
pubmed: 25496155
Ann Diagn Pathol. 2014 Apr;18(2):78-81
pubmed: 24485935
Clin Microbiol Infect. 2014 Jan;20(1):17-21
pubmed: 24350723
Public Health Ethics. 2011 Nov;4(3):226-235
pubmed: 22102849
N Engl J Med. 2017 Mar 2;376(9):856-867
pubmed: 28249147
N Engl J Med. 2013 Aug 1;369(5):401-4
pubmed: 23822655
Genome Med. 2014 Feb 28;6(2):10
pubmed: 24713084
JMIR Public Health Surveill. 2017 Oct 11;3(4):e62
pubmed: 29021131
Biopreserv Biobank. 2013 Jun;11(3):149-52
pubmed: 24850091
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21701-6
pubmed: 21115835
JMIR Public Health Surveill. 2017 Sep 19;3(3):e66
pubmed: 28928112
Camb Q Healthc Ethics. 2012 Jan;21(1):40-50
pubmed: 22152457
PLoS Comput Biol. 2012;8(7):e1002616
pubmed: 22844241
BMC Public Health. 2017 Apr 4;17(1):295
pubmed: 28376752
Vaccine. 2015 Nov 27;33(48):6849-54
pubmed: 26322844
J Infect Dis. 2016 Dec 1;214(suppl_4):S380-S385
pubmed: 28830112
Science. 2014 Mar 14;343(6176):1203-5
pubmed: 24626916

Auteurs

Lester Darryl Geneviève (LD)

Institute for Biomedical Ethics, University of Basel, Basel, Switzerland.

Andrea Martani (A)

Institute for Biomedical Ethics, University of Basel, Basel, Switzerland.

Tenzin Wangmo (T)

Institute for Biomedical Ethics, University of Basel, Basel, Switzerland.

Daniela Paolotti (D)

Institue for Scientific Interchange Foundation, Torino, Italy.

Carl Koppeschaar (C)

De Grote Griepmeting, Science in Action BV, Amsterdam, Netherlands.

Charlotte Kjelsø (C)

Statens Serum Institut, København, Denmark.

Caroline Guerrisi (C)

Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Paris, France.

Marco Hirsch (M)

German Research Center for Artificial Intelligence (DFKI), Kaiserslautern, Germany.

Olivia Woolley-Meza (O)

ETH Zurich, Swiss Federal Institute of Technology, Zurich, Switzerland.
Novartis Pharma AG, Basel, Switzerland.

Paul Lukowicz (P)

German Research Center for Artificial Intelligence (DFKI), Kaiserslautern, Germany.

Antoine Flahault (A)

Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Bernice Simone Elger (BS)

Institute for Biomedical Ethics, University of Basel, Basel, Switzerland.
University Center of Legal Medicine, University of Geneva, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH